These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10518669)

  • 1. Melt pelletisation of a hygroscopic drug in a high shear mixer. Part 1. Influence of process variables.
    Thies R; Kleinebudde P
    Int J Pharm; 1999 Oct; 188(2):131-43. PubMed ID: 10518669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melt pelletisation of a hygroscopic drug in a high shear mixer. Part 2. Mutual compensation of influence variables.
    Thies R; Kleinebudde P
    Eur J Pharm Sci; 2000 Apr; 10(2):103-10. PubMed ID: 10727875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melt pelletization of a hygroscopic drug in a high shear mixer. Part 3. Effects of binder variation.
    Thies R; Kleinebudde P
    Chem Pharm Bull (Tokyo); 2001 Feb; 49(2):140-6. PubMed ID: 11217098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of production variables on the sphericity of melt pellets.
    Heng PW; Wong TW; Chan LW
    Chem Pharm Bull (Tokyo); 2000 Mar; 48(3):420-4. PubMed ID: 10726869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of melting and rheological properties of fatty binders on the melt granulation process in a high-shear mixer.
    Evrard B; Amighi K; Beten D; Delattre L; Moës AJ
    Drug Dev Ind Pharm; 1999 Nov; 25(11):1177-84. PubMed ID: 10596355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of high shear mixer melt granulation process variables using an asymmetrical factorial design.
    Voinovich D; Campisi B; Moneghini M; Vincenzi C; Phan-Tan-Luu R
    Int J Pharm; 1999 Nov; 190(1):73-81. PubMed ID: 10528099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of melt pelletization in a high shear mixer.
    Bukovec P; Kroselj V; Turk S; Vrecer F
    Int J Pharm; 2009 Nov; 381(2):192-8. PubMed ID: 19580855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A priori performance prediction in pharmaceutical wet granulation: testing the applicability of the nucleation regime map to a formulation with a broad size distribution and dry binder addition.
    Kayrak-Talay D; Litster JD
    Int J Pharm; 2011 Oct; 418(2):254-64. PubMed ID: 21530625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of starch-based pellets by hot-melt extrusion.
    Bialleck S; Rein H
    Eur J Pharm Biopharm; 2011 Oct; 79(2):440-8. PubMed ID: 21570466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining formulation and process aspects for optimizing the high-shear wet granulation of common drugs.
    Cavinato M; Andreato E; Bresciani M; Pignatone I; Bellazzi G; Franceschinis E; Realdon N; Canu P; Santomaso AC
    Int J Pharm; 2011 Sep; 416(1):229-41. PubMed ID: 21763764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion.
    Roblegg E; Jäger E; Hodzic A; Koscher G; Mohr S; Zimmer A; Khinast J
    Eur J Pharm Biopharm; 2011 Nov; 79(3):635-45. PubMed ID: 21801834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melt granulation in fluidized bed: a comparative study of spray-on versus in situ procedure.
    Mašić I; Ilić I; Dreu R; Ibrić S; Parojčić J; Srčič S
    Drug Dev Ind Pharm; 2014 Jan; 40(1):23-32. PubMed ID: 23294368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of formulation and processing variables on the granulation kinetics of hot melt granulation (HMG) process.
    Sandhu HK; Chatterji A; Shah NH; Malick AW; Desai D; Zia H
    Pharm Dev Technol; 2007; 12(2):145-51. PubMed ID: 17510885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined experimental and modeling approach to study the effects of high-shear wet granulation process parameters on granule characteristics.
    Pandey P; Tao J; Chaudhury A; Ramachandran R; Gao JZ; Bindra DS
    Pharm Dev Technol; 2013 Feb; 18(1):210-24. PubMed ID: 22780851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melt pelletization with polyethylene glycol in a rotary processor.
    Vilhelmsen T; Kristensen J; Schaefer T
    Int J Pharm; 2004 May; 275(1-2):141-53. PubMed ID: 15081145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation design for optimal high-shear wet granulation using on-line torque measurements.
    Cavinato M; Bresciani M; Machin M; Bellazzi G; Canu P; Santomaso AC
    Int J Pharm; 2010 Mar; 387(1-2):48-55. PubMed ID: 19969055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining drug hydrophobicity in continuous wet granulation within a twin screw extruder.
    Li H; Thompson MR; O'Donnell KP
    Int J Pharm; 2015 Dec; 496(1):3-11. PubMed ID: 26232701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of prolonged release pellets obtained by the melt pelletization process.
    Hamdani J; Moës AJ; Amighi K
    Int J Pharm; 2002 Oct; 245(1-2):167-77. PubMed ID: 12270253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: influence of formulation variables and modelling of agglomerate growth.
    Pauli-Bruns A; Knop K; Lippold BC
    Eur J Pharm Biopharm; 2010 Mar; 74(3):503-12. PubMed ID: 20026401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of melt agglomeration properties of polyethylene glycols using a mixer torque rheometer.
    Johansen A; Schaefer T; Kristensen HG
    Int J Pharm; 1999 Jun; 183(2):155-64. PubMed ID: 10361166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.